PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 7418: Evaluation of chemo-radiation therapy’s effect on the senescence status of tumor microenvironment of HNSCC

View Full Paper
LGLei GaoASAlanna SunRXRuomin Xin

Key Points

  • The study aims to assess how chemoradiation therapy influences the senescence status of the tumor microenvironment in head and neck squamous cell carcinoma.
  • Analyzed bulk immune-targeted RNA sequencing data from 30 HNSCC patients pre- and post-chemoradiotherapy.
  • Utilized single-cell RNA sequencing data from oral cancer samples of 4 HNSCC patients during radiation treatment.
  • Conducted filtering, normalization, integration, and clustering on sequencing data.
  • Employed generative AI to assist in analyzing the data.
  • Post-chemoradiation, myeloid cell activation in immune response was significantly upregulated.
  • Cytokinesis pathways showed significant downregulation after treatment.
  • Key interferon-stimulated genes were notably downregulated post-chemoradiation.
  • Different immune cell pathways indicated altered signaling related to survival and proliferation after radiation.

Abstract

Abstract Background: Cellular senescence is a stress-induced, irreversible arrest of cell proliferation accompanied by a senescence-associated secretory phenotype (SASP), which may impair the immune system’s ability to detect and eliminate cancer cells. Chemotherapy and radiation therapy (RT) are standard treatments for head and neck squamous cell carcinoma (HNSCC) by inducing DNA damage. Despite their therapeutic utility, studies have shown that chemotherapy and RT-induced DNA damage may also cause immune cell senescence in other cancers. The effect of these therapies on the senescence state of the tumor microenvironment (TME) in HNSCC has not been elucidated. We hypothesized that chemoradiation treatment results in the immunosenescence of TME in HNSCC. In this study, we analyzed how chemotherapy and radiation therapy influence the senescence-associated gene programs in the TME of HNSCC. Methods: Bulk immune-targeted RNA sequencing data were obtained from 30 HNSCC patients before and after chemoradiotherapy (GSE193445 from GEO). Single-cell RNA sequencing data were obtained from oral cancer tumor samples of 4 patients with HNSCC (GSE280982) at 3 time points of RT treatment. Filtering, normalization, integration, and clustering were performed on the sequencing data. Generative AI was used for assistance in debugging analyses. Results: Gene Set Enrichment Analysis (GSEA) of bulk RNA-seq data shows that, post-chemoradiation, myeloid cell activation involved in immune response was upregulated (NES = +1.93, padj = 0.0056), while cytokinesis was downregulated (NES = -2.32, padj = 0.0037). Differential expression analysis identified interferon-stimulated genes ISG15 (log2FC = -1.48, padj = 4.9e-07) and IFI6 (log2FC = -1.46, padj = 2.2e-07) were strongly downregulated after chemoradiation. Additional immune-modulatory genes expression such as IGFBP3 (log2FC = -1.56, padj = 6.0e-08) and GAGE family genes (log2FC = -1.79, padj = 0.022) also decreased post-treatment. Single-cell RNA-Seq data show that in individual cell clusters after RT, in CD8+ T cells, the p53 pathway was upregulated (NES = 1.8, padj = 0.0038) and IL-2/STAT5 signaling pathway was suppressed (NES = -1.8, padj = 0.02). In B cells, TNFα signaling (NES = 2.6, padj = 4.1e-07) and apoptosis pathway (NES = 1.66, padj = 0.03) is upregulated. In Tregs, oxidative phosphorylation (NES = 2.6, padj = 6.1e-05) and MYC signaling is upregulated in Tregs (NES = 3.2, padj = 2.5e-08). Conclusion: Preliminary data suggest that innate immune pathways in the TME of HNSCC were suppressed after chemoradiation therapy; the proliferative and survival pathways of CD8+ T cells, B cells, and Tregs are altered as a response to RT. Citation Format: Lan Gao, Alanna Sun, Ruomin Xin, Daniel John, Wei Tse Li, Weg M. Ongkeko. Evaluation of chemo-radiation therapy’s effect on the senescence status of tumor microenvironment of HNSCC abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7418.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gao et al. (2026) studied this question.

synapsesocial.com/papers/69d1fca7a79560c99a0a247bhttps://doi.org/10.1158/1538-7445.am2026-7418
Ask AI
Helpful
Bookmark
Share
View Full Paper